Alan Clayton Sartorelli

Background

Sartorelli, Alan Clayton was born on December 18, 1931 in Chelsea, Massachusetts, United States.

Education

Bachelor of Science, New England College Pharmacy Northeastern U., 1953; Master of Science, Middlebury (Vermont) College, 1955; Doctor of Philosophy, University Wisconsin, 1958; Master of Arts (honorary), Yale University, 1967.

Career

Research chemist, Samuel Roberts Noble Foundation, Ardmore, Oklahoma, 1958-1960; senior research chemist, Samuel Roberts Noble Foundation, 1960-1961; member of faculty department pharmacology, Yale School Medicine, New Haven, Connecticut, since 1961; professor, Yale School Medicine, New Haven, Connecticut, since 1967; head development therapeutics program Comprehensive Cancer Center, Yale School Medicine, New Haven, Connecticut, 1974-1990; department chairman pharmacology, Yale School Medicine, New Haven, Connecticut, 1977-1984; deputy director Comprehensive Cancer Center, Yale School Medicine, New Haven, Connecticut, 1982-1984; director Comprehensive Cancer Center, Yale School Medicine, New Haven, Connecticut, 1984-1993; Alfred Gilman professor pharmacology, Yale School Medicine, New Haven, Connecticut, since 1987; professor epidemiology, Yale School Medicine, New Haven, Connecticut, 1991-1997. Charles B. Smith visiting research professor Memorial Sloan-Kettering Center, 1979. William N. Creasy visiting professor clinical pharmacology Wayne State University, 1983.

Mayo Foundation visiting professor oncology Mayo Clinic, 1983. Walter Hubert lecturer British Association Cancer Research, 1985. Pfizer lecturer in clinical pharmacology U. Connecticut Health Center, 1985.

William N. Creasy visiting professor clinical pharmacology Bowman Gray School Medicine, 1987. Wellcome visiting professor basic science U. Pittsburgh School Medicine, 1990. Member science advisory board ImmunoGen, Inc., since 1981, U. Indiana Cancer Center, 1992, Cancer Institute New Jersey, since 1993, Cell Pathways, Inc., since 1993.

Chairman cancer science advisory board ViraChem., Inc., 1986-1993, The Liposome Company, since 1986, Vion Pharmaceuticals, since 1993, board directors, chairman science advisory board. Chairman visiting science advising committee Columbia University Comprehensive Cancer Center, since 1986. Chairman president's cancer advisory board Fox Chase Cancer Center,1992-.

Member cancer clinical investigation review committee National Cancer Institute, 1968-1972, management consultant to director division cancer treatment, 1975-1977, board science counselors, division cancer treatment, 1978-1981, Chairman of Commission to establish national cooperative drug discovery groups, 1982-1983, chairman special review committee Outstanding Investigator grant applications, 1992, chairman ad hoc contracts technical review group, 1993. Member institutional research grants committee American Cancer Society, 1971-1976, county analysis and projection, 1978-1979. Consultant in biochemistry University Texas M.D. Anderson Hospital and Tumor Clinic, Houston, 1970-1976.

Consultant Sandoz Forschungs-Institut, Vienna, Austria, 1977-1980. Member experimental therapeutics study section National Institutes of Health, 1973-1977, working cadre national large bowel cancer project, 1973-1976. Member of advisory committee Cancer Research Center, Washington University School Medicine, 1971-1975, SLSB Partners, L.P., since 1992.

Member science advising committee U. Iowa Cancer Center, 1979-1983. Member external advising committee Wisconsin Clinical Cancer Center, 1978-1979, Duke Comprehensive Cancer Center, 1983-1994. Member external advisory board U. Arizona Cancer Center, 1982-1992, U. So.Calif.

Cancer Center, 1983-1993, Clinical Cancer Research Center, Brown U., 1980-1986. Member of national program committee 13th International Cancer Congress, 1979-1981. Consultant Bristol-Myers Company, 1982-1993, member selection committee prize in cancerrsch., 1977-1985, chairman, 1979-1981, chairman selection committee award for distinguished achievement in cancer research, 1989-1992.

Board advisors Drug and Vaccine Development Corporation (Center for Public Resources), 1980-1981, Specialized Cancer Center, Mount Sinai Medical Center, 1981-1990, Grace Cancer Drug Center, RoswellPark Memorial Institute, 1986-1989. Member medical and science advising committee grants review subcommittee Leukemia Society American, 1984-1988. Board directors Metastasis Research Society, 1984-1990.

Member program planning committee Mary Lasker-American Cancer Society Conference, 1986. Member external science review committee Massey Cancer Center, 1989-1994. Bd.visitors Moffit Cancer Center United States Florida, 1989-1994.

Member ad hoc consultant group for cancer centers program National Cancer Advisory Board, 1989-1992. Deputy dir.Cancer Prevention Research Unit for Connecticut, 1989-1993, acting director, 1991-1993. Member of national board Cosmetic Toiletry and Fragnance Association's Look Good.Feel Better Program, 1989-1991.

Member organizing committee Conference on Bioreductive Drug Activation, 1993-1994. Chairman of the Board special consultant Institute for Cancer Therapeutics, since 1993.

Achievements

• Alan Clayton Sartorelli has been listed as a noteworthy Pharmacology educator by Marquis Who's Who.

Membership

Board of directors Shubert Performing Arts Center, since 1992, Shubert Opera Board, since 1991, chairman, since 1993. Fellow American Association for the Advancement of Science, New York Academy Sciences. Member American Association Cancer Research (director 1975-1978, 84-87, chairman publications committee 1981-1988, vice president 1985-1986, finance committee 1985-1988, Executive Committee 1985-1989, chairman of the executive committee 1987, president 1986-1987, chairman awards committee 1987, chairman nominating committee 1993-1995, member development committee since 1995), American Chemical Society, American Society Microbiology, American Society Biochemistry and Molecular Biology, American Society Cell Biology, American Society Pharmacology and Experimental Therapeutics (award in experimental therapeutics 1986, award committee 1988, chairman 1992), Association American Cancer Institutions (vice president 1986, board directors 1986-1989,liaison representative to National Cancer Institute 1986, president 1987-1988, Chairman, Board Of Directors 1989), Institute of Medicine of NAS (commission on government industry collaboration in biomedical research and education 1989, member Forum on Drug Development and Regulation since 1989), Connecticut Academy Science and Engineering, Council Biology Editors.

Connections

M. Alice C. Anderson, July 7, 1969.